Home > Publications Database > Proteasomal degradation of the intrinsically disordered protein tau at single-residue resolution > print |
001 | 153283 | ||
005 | 20240420115847.0 | ||
024 | 7 | _ | |a pmc:PMC7439447 |2 pmc |
024 | 7 | _ | |a 10.1126/sciadv.aba3916 |2 doi |
024 | 7 | _ | |a altmetric:86268736 |2 altmetric |
024 | 7 | _ | |a pmid:32832664 |2 pmid |
037 | _ | _ | |a DZNE-2020-01280 |
041 | _ | _ | |a English |
082 | _ | _ | |a 500 |
100 | 1 | _ | |a Ukmar-Godec, Tina |0 P:(DE-2719)9000315 |b 0 |e First author |
245 | _ | _ | |a Proteasomal degradation of the intrinsically disordered protein tau at single-residue resolution |
260 | _ | _ | |a Washington, DC [u.a.] |c 2020 |b Assoc. |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1713534763_11036 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Intrinsically disordered proteins (IDPs) can be degraded in a ubiquitin-independent process by the 20S proteasome. Decline in 20S activity characterizes neurodegenerative diseases. Here, we examine 20S degradation of IDP tau, a protein that aggregates into insoluble deposits in Alzheimer’s disease. We show that cleavage of tau by the 20S proteasome is most efficient within the aggregation-prone repeat region of tau and generates both short, aggregation-deficient peptides and two long fragments containing residues 1 to 251 and 1 to 218. Phosphorylation of tau by the non-proline–directed Ca2+/calmodulin-dependent protein kinase II inhibits degradation by the 20S proteasome. Phosphorylation of tau by GSK3β, a major proline-directed tau kinase, modulates tau degradation kinetics in a residue-specific manner. The study provides detailed insights into the degradation products of tau generated by the 20S proteasome, the residue specificity of degradation, single-residue degradation kinetics, and their regulation by posttranslational modification. |
536 | _ | _ | |a 342 - Disease Mechanisms and Model Systems (POF3-342) |0 G:(DE-HGF)POF3-342 |c POF3-342 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef |
700 | 1 | _ | |a Fang, P. |0 0000-0002-6217-5450 |b 1 |
700 | 1 | _ | |a Ibanez de Opakua, Alain |0 P:(DE-2719)2812657 |b 2 |
700 | 1 | _ | |a Henneberg, F. |0 0000-0003-3444-0947 |b 3 |
700 | 1 | _ | |a Godec, A. |0 0000-0003-1888-6666 |b 4 |
700 | 1 | _ | |a Pan, K.-T. |0 0000-0001-6974-5324 |b 5 |
700 | 1 | _ | |a Cima Omori, Maria Sol |0 P:(DE-2719)2812201 |b 6 |u dzne |
700 | 1 | _ | |a Chari, A. |0 0000-0001-6220-9828 |b 7 |
700 | 1 | _ | |a Mandelkow, Eckhard |0 P:(DE-2719)2541671 |b 8 |
700 | 1 | _ | |a Urlaub, H. |b 9 |
700 | 1 | _ | |a Zweckstetter, Markus |0 P:(DE-2719)2810591 |b 10 |e Last author |
773 | _ | _ | |a 10.1126/sciadv.aba3916 |g Vol. 6, no. 30, p. eaba3916 - |0 PERI:(DE-600)2810933-8 |n 30 |p eaba3916 - |t Science advances |v 6 |y 2020 |x 2375-2548 |
856 | 4 | _ | |u https://advances.sciencemag.org/content/6/30/eaba3916 |
856 | 4 | _ | |u https://pub.dzne.de/record/153283/files/DZNE-2020-01280.pdf |y OpenAccess |
856 | 4 | _ | |u https://pub.dzne.de/record/153283/files/DZNE-2020-01280.pdf?subformat=pdfa |x pdfa |y OpenAccess |
909 | C | O | |o oai:pub.dzne.de:153283 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)9000315 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2812657 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 6 |6 P:(DE-2719)2812201 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)2541671 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 10 |6 P:(DE-2719)2810591 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-342 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Disease Mechanisms and Model Systems |x 0 |
914 | 1 | _ | |y 2020 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-08 |
915 | _ | _ | |a Creative Commons Attribution-NonCommercial CC BY-NC (No Version) |0 LIC:(DE-HGF)CCBYNCNV |2 V:(DE-HGF) |b DOAJ |d 2020-08-22 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2022-11-08 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b SCI ADV : 2021 |d 2022-11-08 |
915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b SCI ADV : 2021 |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2021-09-20T13:50:30Z |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2020-08-22 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2021-09-20T13:50:30Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-08 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-08 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2020-08-22 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-08-22 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2020-08-22 |
920 | 1 | _ | |0 I:(DE-2719)6000014 |k Göttingen common |l Göttingen common |x 0 |
920 | 1 | _ | |0 I:(DE-2719)1410001 |k AG Zweckstetter |l Translational Structural Biology |x 1 |
920 | 1 | _ | |0 I:(DE-2719)1013014 |k AG Mandelkow 1 |l Structural Principles of Neurodegeneration |x 2 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-2719)6000014 |
980 | _ | _ | |a I:(DE-2719)1410001 |
980 | _ | _ | |a I:(DE-2719)1013014 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|